HRL Hormel Foods
A solid staples franchise priced for full recovery; worth about 12-13, not 22.6, unless margins return above 10%.
The story
Hormel is a mature protein and branded packaged-foods company (SPAM, Hormel, Jennie-O, Skippy, Planters) whose brands and retail and foodservice distribution give it a modest but real moat. It is in late maturity: revenue has been flat to slightly down for five years, and margins have fallen from about 11% to under 5% TTM. Commodity turkey and pork costs, Planters underperformance, impairments and transformation spending have hit at the same time. Value depends on whether the transformation program restores mid-to-high single-digit margins, not on growth.
I am keeping all prior drivers. The drop in TTM margin from 6.1% to 4.9% looks driven mostly by impairments and one-time transformation and commodity charges rather than a permanent loss of brand economics, so a 9.2% target (below the 10-11% historical peak) still holds. Sales-to-capital stays at 1.5 on an incremental basis because a low-growth staples firm needs little new capital, even though the reported ratio is 1.13. The price rising to 22.6 while margins fell further shows the market expects a fuller recovery than I do. That widens the gap, but it does not justify a promotional margin assumption.
Value drivers
| Revenue growth (Y1) | 1.5% |
| Terminal growth | 2.5% |
| Forecast horizon | 6y |
| Target operating margin | 9.2% |
| Years to target margin | 5 |
| Sales-to-capital | 1.50 |
| Beta | 0.70 |
| Failure probability | 1.0% |
| Cost of capital (WACC) | 7.5% |
| Terminal WACC | 8.6% |
Valuation bridge
| PV of explicit FCFF | 2.56B |
| PV of terminal value | 6.97B |
| Equity value | 7.26B |
| ÷ shares → per share | $13.19 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 12.33B | 1.5% | 5.8% | 514.61M | 121.47M | 393.14M | 365.63M |
| 2 | 12.54B | 1.7% | 6.6% | 600.20M | 139.73M | 460.47M | 398.28M |
| 3 | 12.78B | 1.9% | 7.5% | 689.90M | 158.82M | 531.07M | 427.21M |
| 4 | 13.05B | 2.1% | 8.3% | 784.33M | 178.88M | 605.45M | 452.96M |
| 5 | 13.35B | 2.3% | 9.2% | 884.14M | 200.03M | 684.12M | 476.00M |
| 6 | 13.68B | 2.5% | 9.2% | 906.25M | 222.42M | 683.83M | 442.50M |
Key risks
- Margin trough proves structural: private-label share gains and retailer pricing power cap recovery near 7%
- Turkey and pork commodity volatility and avian influenza keep Jennie-O and pork-related earnings depressed
- Further impairments or a value-destroying acquisition, repeating the Planters outcome, with net debt already at 2.2B
Catalysts
- Evidence that transformation savings are reaching adjusted operating margin in the next two or three quarters
- Portfolio pruning or divestiture of underperforming brands that sharpens returns on capital